{
    "pubmed_id": "33915337",
    "study_identifier": "PMID33915337_study-01",
    "study_name": "Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series",
    "publication_title": "Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series",
    "study_objective": "To assess intro-host viral heterogeneity and the impact on viral transmission and immune escape",
    "study_description": "There is increasing concern that persistent infection of SARS-CoV-2 within immunocompromised hosts could serve as a reservoir for mutation accumulation and subsequent emergence of novel strains with the potential to evade immune responses. We describe three patients with acute lymphoblastic leukemia who were persistently positive for SARS-CoV-2 by real-time polymerase chain reaction. Viral viability from longitudinally-collected specimens was assessed. Whole-genome sequencing and serological studies were performed to measure viral evolution and evidence of immune escape. We found compelling evidence of ongoing replication and infectivity for up to 162 days from initial positive by subgenomic RNA, single-stranded RNA, and viral culture analysis. Our results reveal a broad spectrum of infectivity, host immune responses, and accumulation of mutations, some with the potential for immune escape. Our results highlight the potential need to reassess infection control precautions in the management and care of immunocompromised patients. Routine surveillance of mutations and evaluation of their potential impact on viral transmission and immune escape should be considered.",
    "primary_institution_name": "Stanford University",
    "study_personnel": [
        {
            "personnel_id": "PMID33915337_personnel-01",
            "honorific": "",
            "last_name": "Boyd",
            "first_name": "Scott",
            "suffixes": "",
            "organization": "Stanford University",
            "orchid_id": "",
            "email": "sboyd1@stanford.edu",
            "seronet_title_in_study": "SeroNet Principal Investigator",
            "role_in_study": "Investigator",
            "site_name": "Stanford University"
        }
    ],
    "study_file": [
        {
            "study_file_name": "mmc1.pdf",
            "study_file_description": "Case Report Check List",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "mmc2.pdf",
            "study_file_description": "Supplementary figures and data",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "mmc3.pdf",
            "study_file_description": "Materials Transfer Agreement",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "GISAID ascension numbers.txt",
            "study_file_description": "GISAID ascension numbers",
            "study_file_type": "Study Data"
        }
    ],
    "study_link": [],
    "research_focus": "Infection Response",
    "study_type": "Clinical Research",
    "keyword": [
        "SARS-CoV-2; case report; immunocompromised; pediatric; persistent infection; variants"
    ],
    "clinical_study_design": "Case Report",
    "in_silico_model_type": "",
    "protocol": {
        "protocol_id": "PMID33915337_protocol-01",
        "protocol_file_name": "PMID33915337_protocol-01.txt",
        "protocol_name": "PMID33915337_protocol-01",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19",
        "Cancer"
    ],
    "sars_cov_2_vaccine_type": [
        "N/A"
    ],
    "clinical_outcome_measure": "Infection control precautions in the management and care of immunocompromised patients",
    "enrollment_start_date": "2020-05-07",
    "enrollment_end_date": "2020-11-21",
    "number_of_study_subjects": 3,
    "age_unit": "Years",
    "minimum_age": 2,
    "maximum_age": 21,
    "study_human_cohort": [
        {
            "arm_id": "PMID33915337_human_subject-01",
            "arm_name": "Female patient with acute lymphoblastic leukemia (ALL)",
            "study_population_description": "Patient 1 is a previously healthy 3-year-old female, B-cell ALL",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [
                "assessment_recorded_pv"
            ],
            "study_location": [
                "US: California"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Acute COVID-19 (< 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "From Electronic Health Record"
            ],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "n/a"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [
                "Fever, Cough, Sore Throat, Vomiting, Abdominal Pain, Malaise"
            ],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID33915337_human_subject-02",
            "arm_name": "Male patient with acute lymphoblastic leukemia (ALL)",
            "study_population_description": "Patient 2 is a 21-year-old male who was previously diagnosed with B-cell ALL six months prior",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [
                "assessment_recorded_pv"
            ],
            "study_location": [
                "US: California"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Acute COVID-19 (< 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "From Electronic Health Record"
            ],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "n/a"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [
                "Fever, Cough, Vomiting. Malaise , Shortness of Breath, Congestion, Abdominal Pain"
            ],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID33915337_human_subject-03",
            "arm_name": "Male patient with acute lymphoblastic leukemia (ALL)",
            "study_population_description": "Patient 3 is a 2-year-old male who was diagnosed with high-risk B-cell ALL seven months prior",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [
                "assessment_recorded_pv"
            ],
            "study_location": [
                "US: California"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Acute COVID-19 (< 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [
                "From Electronic Health Record"
            ],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [
                "n/a"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [
                "Fever, Cough, Vomiting. Malaise , Shortness of Breath, Congestion, Abdominal Pain"
            ],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [],
    "planned_visit": [
        {
            "visit_id": "PMID33915337_visit-01",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 1,
            "visit_min_start_day": 1,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-02",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 2,
            "visit_min_start_day": 1,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-03",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 3,
            "visit_min_start_day": 1,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-04",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 4,
            "visit_min_start_day": 78,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-05",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 5,
            "visit_min_start_day": 103,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-06",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 6,
            "visit_min_start_day": 110,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-07",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 7,
            "visit_min_start_day": 123,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-08",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 8,
            "visit_min_start_day": 130,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-09",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 9,
            "visit_min_start_day": 137,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-10",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 10,
            "visit_min_start_day": 144,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-11",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 11,
            "visit_min_start_day": 158,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-12",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 12,
            "visit_min_start_day": 165,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33915337_visit-13",
            "visit_name": "Blood, Nasopharyngeal swabs or combined oropharyngeal and nares swabs",
            "visit_order_number": 13,
            "visit_min_start_day": 172,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID33915337_human_subject-01, PMID33915337_human_subject-02, PMID33915337_human_subject-03"
            ],
            "associated_first_planned_visit_id": [
                "PMID33915337_visit-01, PMID33915337_visit-02, PMID33915337_visit-03, PMID33915337_visit-04, PMID33915337_visit-05, PMID33915337_visit-06, PMID33915337_visit-07, PMID33915337_visit-08, PMID33915337_visit-09, PMID33915337_visit-10, PMID33915337_visit-11, PMID33915337_visit-12, PMID33915337_visit-13"
            ],
            "assay_type": "PCR",
            "experiment_name": "Detection of SARS-CoV-2 RNA",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Nasal Swab",
                "Multiple Immune Cell types (Tissue/Nasopharyngeal Sample/Bronchoaleveolar Lavage)"
            ],
            "biospecimen_collection_point": [
                "Post-acute Sequelae of COVID-19"
            ],
            "sars_cov_2_antigen": [],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [],
            "antibody_isotype": [],
            "reporting_units": "",
            "assay_reporting_format": ""
        },
        {
            "arm_id": [
                "PMID33915337_human_subject-01, PMID33915337_human_subject-02, PMID33915337_human_subject-04"
            ],
            "associated_first_planned_visit_id": [
                "PMID33915337_visit-01, PMID33915337_visit-02, PMID33915337_visit-03, PMID33915337_visit-04, PMID33915337_visit-05, PMID33915337_visit-06, PMID33915337_visit-07, PMID33915337_visit-08, PMID33915337_visit-09, PMID33915337_visit-10, PMID33915337_visit-11, PMID33915337_visit-12, PMID33915337_visit-14"
            ],
            "assay_type": "ELISA",
            "experiment_name": "Measurement of anti-SARS-CoV-2 antibodies in serum",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Blood"
            ],
            "biospecimen_collection_point": [
                "Post-acute Sequelae of COVID-20"
            ],
            "sars_cov_2_antigen": [
                "Receptor Binding Domain (RBD), Nucleocapsid, S1"
            ],
            "assay_use": "",
            "manufacture": "EUROIMMUN",
            "catalog_number": "",
            "virus_target": [
                "SARS-CoV-2 spike"
            ],
            "antibody_isotype": [
                "IgA, IgG, IgM"
            ],
            "reporting_units": "",
            "assay_reporting_format": ""
        },
        {
            "arm_id": [
                "PMID33915337_human_subject-01, PMID33915337_human_subject-02, PMID33915337_human_subject-03"
            ],
            "associated_first_planned_visit_id": [
                "PMID33915337_visit-01, PMID33915337_visit-02, PMID33915337_visit-03, PMID33915337_visit-04, PMID33915337_visit-05, PMID33915337_visit-06, PMID33915337_visit-07, PMID33915337_visit-08, PMID33915337_visit-09, PMID33915337_visit-10, PMID33915337_visit-11, PMID33915337_visit-12, PMID33915337_visit-13"
            ],
            "assay_type": "PCR",
            "experiment_name": "Subgenomic SARS-CoV-2 RT-PCR",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Blood"
            ],
            "biospecimen_collection_point": [
                "Post-acute Sequelae of COVID-19"
            ],
            "sars_cov_2_antigen": [],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [],
            "antibody_isotype": [],
            "reporting_units": "",
            "assay_reporting_format": ""
        },
        {
            "arm_id": [
                "PMID33915337_human_subject-01, PMID33915337_human_subject-02, PMID33915337_human_subject-03"
            ],
            "associated_first_planned_visit_id": [
                "PMID33915337_visit-01, PMID33915337_visit-02, PMID33915337_visit-03, PMID33915337_visit-04, PMID33915337_visit-05, PMID33915337_visit-06, PMID33915337_visit-07, PMID33915337_visit-08, PMID33915337_visit-09, PMID33915337_visit-10, PMID33915337_visit-11, PMID33915337_visit-12, PMID33915337_visit-13"
            ],
            "assay_type": "PCR",
            "experiment_name": "Multiplex PCR + seq",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Blood"
            ],
            "biospecimen_collection_point": [
                "Post-acute Sequelae of COVID-19"
            ],
            "sars_cov_2_antigen": [],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [],
            "antibody_isotype": [],
            "reporting_units": "",
            "assay_reporting_format": ""
        },
        {
            "arm_id": [
                "PMID33915337_human_subject-01, PMID33915337_human_subject-02, PMID33915337_human_subject-03"
            ],
            "associated_first_planned_visit_id": [
                "PMID33915337_visit-01, PMID33915337_visit-02, PMID33915337_visit-03, PMID33915337_visit-04, PMID33915337_visit-05, PMID33915337_visit-06, PMID33915337_visit-07, PMID33915337_visit-08, PMID33915337_visit-09, PMID33915337_visit-10, PMID33915337_visit-11, PMID33915337_visit-12, PMID33915337_visit-13"
            ],
            "assay_type": "Whole Genome Sequencing",
            "experiment_name": "Whole genome seq",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Blood"
            ],
            "biospecimen_collection_point": [
                "Post-acute Sequelae of COVID-19"
            ],
            "sars_cov_2_antigen": [],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [],
            "antibody_isotype": [],
            "reporting_units": "",
            "assay_reporting_format": ""
        }
    ],
    "geriatric_subjects": "Not Specified",
    "pediatric_subjects": "Yes",
    "pregnant_subjects": "Not Specified",
    "sars_cov_2_antibodies_measured": "Not Specified",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Not Specified",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID33915337_inexcl-02",
            "inclusion_criterion": "Pediatric subjects",
            "inclusion_criterion_category": "inclusion"
        }
    ]
}
